Back to Results
First PageMeta Content
Cell biology / Developmental biology / Oncology / Embryonic stem cell / Germ cell / Cell culture / Leukemia inhibitory factor / Homeobox protein NANOG / Adult stem cell / Biology / Stem cells / Biotechnology


IN THE UNITED STATES PATENT AND TRADEMARK OFFICE In the matter of: Reexamination Control. No. 95/000,154 Art Unit:
Add to Reading List

Document Date: 2014-11-04 03:32:25


Open Document

File Size: 374,15 KB

Share Result on Facebook

City

New York / Oxford / /

Company

1RL Press / Cold Spring Harbor Press / NIH Human Embryonic Stem Cell Training Course and Co / GenPharm International / Hana Biologics / Thomson / Arcos BioScience / Incyte Genomics / Cold Spring Harbor Laboratory / Thieme Inc. / Incyte / /

Country

United States / /

Event

Patent Issuance / /

Facility

University of Oregon / University of Washington / Burnham Institute / /

IndustryTerm

biotechnology / transgenic technology / human stem cell technology / /

MedicalCondition

leukemia / embryonal carcinoma / Testicular Cancer / Diabetes / teratocarcinoma stem cells / teratocarcinomas / /

Organization

Melinda Gates Foundation / University of Washington / Burnham Institute for Medical Research / University of Oregon / International Society for Stem Cell Research / Foundation for Taxpayer and Consumer Rights / U.S. Patent and Trademark Office / Alzheimer's Association / Burnham Institute / Public Patent Foundation / Foundation for Taxpayers and Consumer Rights / NIH Exploratory Center for Human Stem Cell Research / Art Unit / /

Person

Gardner / JEANNE F. LORING / Brook / Robertson / Gary L. Kunz / /

Position

same author / counsel / advisor / stem cell scientist / Director / chair / Director of the Stem Cell Resource / /

Product

ES / /

ProvinceOrState

Oregon / New York / /

PublishedMedium

Molecular Biology / /

Technology

Genomics / human stem cell technology / biotechnology / STEM CELLS / on using embryonic stem cells to generate medically useful cell lines / /

SocialTag